TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate

Authors

Edmond K. Kabagambe, University of Alabama - BirminghamFollow
Stephen P. Glasser, University of Alabama - BirminghamFollow
Jose M. Ordovas, Tufts University
Daruneewan Warodomwichit, Mahidol University
Michael Y. Tsai, University of Minnesota - Twin Cities
Paul N. Hopkins, University of Utah
Ingrid B. Borecki, Washington University School of Medicine in St. LouisFollow
Mary Wojczynski, University of Alabama - Birmingham
Donna K. Arnett, University of Alabama - BirminghamFollow

Journal

Diabetology & Metabolic Syndrome

Publication Date

2009

Volume

1

Inclusive Pages

16

Document Type

Open Access Publication

Rights and Permissions

Diabetology & Metabolic Syndrome 2009, 1:16 http://www.dmsjournal.com/content/1/1/16 © 2009 Kabagambe et al; licensee BioMed Central Ltd.

Recommended Citation

Kabagambe, Edmond K.; Glasser, Stephen P.; Ordovas, Jose M.; Warodomwichit, Daruneewan; Tsai, Michael Y.; Hopkins, Paul N.; Borecki, Ingrid B.; Wojczynski, Mary; and Arnett, Donna K., "TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate." Diabetology & Metabolic Syndrome. 1, 16. (2009).
https://digitalcommons.wustl.edu/open_access_pubs/351